Zurich Cantonal Bank’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.19M | Sell |
55,795
-34,013
| -38% | -$1.86M | 0.01% | 889 |
|
|
2026
Q1 | $5.07M | Buy |
89,808
+28,408
| +46% | +$1.66M | 0.01% | 646 |
|
|
2025
Q4 | $3.65M | Sell |
61,400
-99,451
| -62% | -$5.41M | 0.01% | 713 |
|
|
2025
Q3 | $8.71M | Sell |
160,851
-55,929
| -26% | -$3.2M | 0.02% | 489 |
|
|
2025
Q2 | $11.9M | Buy |
216,780
+8,325
| +4% | +$490K | 0.03% | 423 |
|
|
2025
Q1 | $14.7M | Buy |
208,455
+9,699
| +5% | +$653K | 0.04% | 366 |
|
|
2024
Q4 | $13.1M | Buy |
198,756
+101,794
| +105% | +$6.82M | 0.04% | 378 |
|
|
2024
Q3 | $6.82M | Buy |
96,962
+2,588
| +3% | +$216K | 0.02% | 507 |
|
|
2024
Q2 | $7.77M | Buy |
94,374
+1,778
| +2% | +$148K | 0.03% | 457 |
|
|
2024
Q1 | $8.09M | Buy |
92,596
+14,486
| +19% | +$1.3M | 0.03% | 445 |
|
|
2023
Q4 | $7.53M | Buy |
78,110
+42,250
| +118% | +$3.74M | 0.03% | 451 |
|
|
2023
Q3 | $3.17M | Sell |
35,860
-556
| -2% | -$49.5K | 0.01% | 601 |
|
|
2023
Q2 | $3.16M | Buy |
36,416
+3,171
| +10% | +$298K | 0.01% | 608 |
|
|
2023
Q1 | $3.23M | Sell |
33,245
-61
| -0.2% | -$6.32K | 0.02% | 591 |
|
|
2022
Q4 | $3.45M | Sell |
33,306
-459
| -1% | -$43.1K | 0.02% | 554 |
|
|
2022
Q3 | $2.86M | Buy |
33,765
+4,012
| +13% | +$357K | 0.02% | 589 |
|
|
2022
Q2 | $2.47M | Sell |
29,753
-1,412
| -5% | -$112K | 0.01% | 634 |
|
|
2022
Q1 | $2.4M | Buy |
31,165
+1,771
| +6% | +$148K | 0.01% | 674 |
|
|
2021
Q4 | $2.6M | Sell |
29,394
-14,733
| -33% | -$1.22M | 0.01% | 678 |
|
|
2021
Q3 | $3.41M | Sell |
44,127
-1,811
| -4% | -$143K | 0.02% | 613 |
|
|
2021
Q2 | $3.83M | Buy |
45,938
+251
| +0.5% | +$19.9K | 0.02% | 561 |
|
|
2021
Q1 | $3.45M | Buy |
45,687
+7,346
| +19% | +$600K | 0.02% | 568 |
|
|
2020
Q4 | $3.36M | Buy |
38,341
+973
| +3% | +$77.1K | 0.02% | 589 |
|
|
2020
Q3 | $2.84M | Buy |
37,368
+8,347
| +29% | +$845K | 0.02% | 600 |
|
|
2020
Q2 | $3.58M | Sell |
29,021
-8,492
| -23% | -$844K | 0.03% | 470 |
|
|
2020
Q1 | $3.17M | Buy |
37,513
+2,649
| +8% | +$228K | 0.03% | 477 |
|
|
2019
Q4 | $2.95M | Hold |
34,864
| – | – | 0.02% | 569 |
|
|
2019
Q3 | $2.35M | Hold |
34,864
| – | – | 0.02% | 619 |
|
|
2019
Q2 | $2.99M | Sell |
34,864
-8,701
| -20% | -$744K | 0.03% | 538 |
|
|
2019
Q1 | $3.87M | Buy |
43,565
+1,470
| +3% | +$136K | 0.03% | 463 |
|
|
2018
Q4 | $3.58M | Buy |
42,095
+5,217
| +14% | +$496K | 0.04% | 453 |
|
|
2018
Q3 | $3.58M | Sell |
36,878
-645
| -2% | -$64.4K | 0.03% | 506 |
|
|
2018
Q2 | $3.54M | Hold |
37,523
| – | – | 0.03% | 508 |
|
|
2018
Q1 | $3.04M | Sell |
37,523
-286
| -0.8% | -$24.5K | 0.03% | 535 |
|
|
2017
Q4 | $3.37M | Sell |
37,809
-1,696
| -4% | -$147K | 0.03% | 504 |
|
|
2017
Q3 | $3.68M | Sell |
39,505
-296
| -0.7% | -$26.2K | 0.03% | 469 |
|
|
2017
Q2 | $3.62M | Sell |
39,801
-1,628
| -4% | -$148K | 0.04% | 481 |
|
|
2017
Q1 | $3.64M | Sell |
41,429
-1,611
| -4% | -$143K | 0.04% | 486 |
|
|
2016
Q4 | $3.56M | Buy |
43,040
+4,042
| +10% | +$348K | 0.04% | 483 |
|
|
2016
Q3 | $3.61M | Buy |
38,998
+17,510
| +81% | +$1.65M | 0.04% | 472 |
|
|
2016
Q2 | $1.67M | Hold |
21,488
| – | – | 0.02% | 579 |
|
|
2016
Q1 | $1.77M | Hold |
21,488
| – | – | 0.02% | 574 |
|
|
2015
Q4 | $2.25M | Buy |
21,488
+6,184
| +40% | +$646K | 0.03% | 505 |
|
|
2015
Q3 | $1.61M | Buy |
15,304
+1,036
| +7% | +$138K | 0.02% | 579 |
|
|
2015
Q2 | $1.95M | Sell |
14,268
-6,578
| -32% | -$815K | 0.03% | 534 |
|
|
2015
Q1 | $2.6M | Buy |
20,846
+5,421
| +35% | +$574K | 0.04% | 451 |
|
|
2014
Q4 | $1.39M | Buy |
15,425
+5,215
| +51% | +$434K | 0.04% | 460 |
|
|
2014
Q3 | $737K | Sell |
10,210
-49,246
| -83% | -$3.24M | 0.02% | 593 |
|
|
2014
Q2 | $3.7M | Buy |
59,456
+21,146
| +55% | +$1.28M | 0.11% | 229 |
|
|
2014
Q1 | $2.61M | Sell |
38,310
-14,136
| -27% | -$1.04M | 0.08% | 281 |
|
|
2013
Q4 | $3.69M | Sell |
52,446
-2,791
| -5% | -$190K | 0.12% | 197 |
|
|
2013
Q3 | $3.99M | Sell |
55,237
-30,128
| -35% | -$2M | 0.14% | 154 |
|
|
2013
Q2 | $4.76M | Buy |
+85,365
| New | +$5.32M | 0.17% | 133 |
|
Other funds holding BMRN
VPC
Zurich Cantonal Bank's BMRN Position: Q2 2026 in Review
Zurich Cantonal Bank reduced its BioMarin Pharmaceuticals (BMRN) stake by 38% in Q2 2026, selling an estimated $1.86M and leaving 55,795 shares worth $3.19M. The position accounts for 0.01% of the portfolio, ranked #889.
Zurich Cantonal Bank first reported a position in BMRN in Q2 2013 and has held it in 53 quarters since. The position peaked at $14.7M in Q1 2025. 564 funds tracked by Wall St. Rank hold BMRN as of Q2 2026.
- Zurich Cantonal Bank held 55,795 shares of BioMarin Pharmaceuticals worth $3.19M as of Q2 2026.
- Zurich Cantonal Bank sold 34,013 BioMarin Pharmaceuticals shares in Q2 2026, an estimated $1.86M.
- BioMarin Pharmaceuticals made up 0.01% of Zurich Cantonal Bank's portfolio in Q2 2026, its #889 holding.
- Zurich Cantonal Bank first reported a position in BioMarin Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
- Zurich Cantonal Bank's BioMarin Pharmaceuticals position peaked at $14.7M in Q1 2025.
- 564 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2026.
Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.